BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31815952)

  • 21. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
    Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
    Takagi T; Yoshida K; Wada A; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
    Int J Clin Oncol; 2020 May; 25(5):892-898. PubMed ID: 32048086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors of patients with T3N0M0 renal cell carcinoma: a single-center retrospective study of 182 patients].
    Peng D; Li XS; Zhang CJ; Yang KW; Tang Q; Zhang L; Yu XT; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):806-811. PubMed ID: 27752160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
    Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
    Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.
    Shah PH; Moreira DM; Okhunov Z; Patel VR; Chopra S; Razmaria AA; Alom M; George AK; Yaskiv O; Schwartz MJ; Desai M; Vira MA; Richstone L; Landman J; Shalhav AL; Gill I; Kavoussi LR
    J Urol; 2016 Aug; 196(2):327-34. PubMed ID: 26907508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
    Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
    Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
    Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
    Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
    Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
    Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy.
    Ha YS; Kim WT; Yun SJ; Lee SC; Kim WJ; Park YH; Kang SH; Hong SH; Byun SS; Kim YJ
    Ann Surg Oncol; 2013 Oct; 20(11):3662-8. PubMed ID: 23907313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal cell carcinoma in young patients is associated with poorer prognosis.
    Lee LS; Yuen JS; Sim HG
    Ann Acad Med Singap; 2011 Sep; 40(9):401-6. PubMed ID: 22065033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
    Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
    World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
    Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
    Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors.
    Mouracade P; Kara O; Maurice MJ; Dagenais J; Malkoc E; Nelson RJ; Kaouk JH
    J Urol; 2017 Jun; 197(6):1403-1409. PubMed ID: 27993666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term oncologic outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: a multi-institutional comparative study.
    Park YH; Lee ES; Kim HH; Kwak C; Ku JH; Lee SE; Byun SS; Hong SK; Kim YJ; Kang SH; Hong SH
    J Laparoendosc Adv Surg Tech A; 2014 Aug; 24(8):556-62. PubMed ID: 25007232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
    Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
    Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.
    Zhang ZL; Chen W; Li YH; Liu ZW; Luo JH; Lau W; Tan MH; Zhou FJ
    Chin J Cancer; 2011 Nov; 30(11):772-8. PubMed ID: 22035858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.